The use of hplc as a tool for neonatal cord blood screening of haemoglobinopathy - a validation study
Conclusions: The study validated the earlier observation by 100% concordance with results of CBC and HPLC. Presence of Hb Bart ’s at birth does not always mean the presence of alpha thalassemia, as subjects with Hb Bart’s was below 1% by quantitation, were shown to be normal by molecular studies. Key Words: Neonatal, screening, HPLC validation, haemoglobinopathy, sickle cell disease, thalassaemia
Source: Mediterranean Journal of Hematology and Infectious Diseases - Category: Hematology Source Type: research
More News: Anemia | Hematology | Infectious Diseases | Medical Ethics | Middle East Health | Oman Health | Perinatology & Neonatology | Research | Sickle Cell Anemia | Study